Drug intelligence / Profile preview

cilazaprilat

Development stage
Unknown
Lead developer
Roche
Modality
Small Molecules
Administration
Oral
01

Overview

Cilazaprilat is the active metabolite of cilazapril, a long-acting angiotensin-converting enzyme (ACE) inhibitor. It works by inhibiting ACE, thereby blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This leads to decreased vasoconstriction and reduced sodium and water reabsorption via aldosterone, resulting in lower blood pressure and improved symptoms in heart failure. Cilazaprilat is used primarily for the treatment of hypertension and congestive heart failure[1][4][5][6]. The drug also helps protect kidney function in patients with diabetic nephropathy[7]. Cilazapril is a prodrug that is hydrolyzed after absorption to form cilazaprilat, which exerts the pharmacological effects[5].

Other names
cilazaprilat
02

Targets

ACE (Angiotensin Converting Enzyme)

Beyond the preview

Go deeper on cilazaprilat.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cilazaprilat.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call